AI+医疗有望加速！资金涌入医疗设备ETF、创新药ETF天弘

Group 1 - The core viewpoint is that the integration of AI in healthcare and pharmaceuticals is gaining momentum, with significant stock price increases in related companies such as Meinian Health and Zhaoyan New Drug [1] - The Medical Equipment ETF (159873) has seen continuous capital inflow over the past four days, totaling 26.5 million yuan, reaching new highs in both scale and shares since its inception [2] - The Medical Equipment ETF has a high concentration in brain-computer interface technology, accounting for over 17%, with nearly 80% of its components from the Sci-Tech Innovation Board and the Growth Enterprise Market, indicating strong technological attributes [2] Group 2 - The Innovative Drug ETF Tianhong (517380) has experienced net inflows for six consecutive days, with a total of 254 million yuan in the last five days, reflecting strong investor interest [3] - The Innovative Drug ETF spans the Shanghai, Hong Kong, and Shenzhen markets, covering the entire industry chain from preclinical research to commercialization, which helps mitigate investment uncertainties [3] - OpenAI's launch of ChatGPTHealth marks the beginning of an AI-driven healthcare era, enhancing privacy through data isolation and involving over 260 doctors from 60 countries in model optimization [3]